David W Ellison: Influence Statistics

David W Ellison

David W Ellison

Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA | Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee, ...

David W Ellison: Expert Impact

Concepts for which David W Ellison has direct influence: Astrocytic tumours , Central nervous , Young children , Situ hybridization .

David W Ellison: KOL impact

Concepts related to the work of other authors for which for which David W Ellison has influence: Brain tumors , Central nervous , Stem cells , Gene expression , Cell proliferation , Quinolinic acid , Glioma patients .

KOL Resume for David W Ellison

Year
2022

Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

2021

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105 USA

2020

Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA

St. Jude Children's Research Hospital, Memphis, TN;

2019

St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA;

Department of Oncology, Division of Neuro-Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

2018

Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA

2017

Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee

2016

Department of Pathology, St Jude Children’s Research Hospital, Memphis, TN 38105-3678 USA

Pathology (R.G.T., J.D., K.H., D.W.E.)

2015

St. Jude's Children's Research Hospital Department of Pathology Memphis Tennessee

Department of Pathology, St Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA

Giles W. Robinson, Brent A. Orr, Gang Wu, Tong Lin, Ibrahim Qaddoumi, Sue C. Kaste, Michael Rusch, Sariah J. Allen, Arzu Onar-Thomas, Clinton F. Stewart, James M. Boyett, Richard J. Gilbertson, David W. Ellison, and Amar Gajjar, St Jude Children's Research Hospital, Memphis, TN; Sridharan Gururangan and Annick Desjardins, Duke University Medical Center, Durham, NC; Roger J. Packer, Children's National Medical Center, Washington, DC; Stewart Goldman, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Michael D. Prados, University of California San Francisco, San Francisco, CA; Murali Chintagumpala, Texas Children's Cancer Center, Houston, TX; Naoko Takebe, National Cancer Institute, Bethesda, MD; Maryam Fouladi, Cincinnati Children's Hospital, Cincinnati, OH; and Tom Curran, Children's Hospital of Philadelphia, Philadelphia, PA.

2014

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105

Centre for Molecular Oncology, Barts Cancer Institute, EC1M 6BQ, London, UK

St Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project, USA

2013

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, United Kingdom

Authors' Affiliations: Departments of Oncology, Pharmaceutical Sciences, Pathology, Radiological Sciences, Biostatistics, and Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, Tennessee; Center for Neuroscience Research, Children's National Medical Center, Washington, DC; Division of Hematology–Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Pediatrics, Texas Children's Hospital, Houston, Texas; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland; and Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Department of Pathology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis 38105, Tennessee

St. Jude Children's Research Hospital, Memphis, TN

2012

Departments of Computational Biology (Drs Zhang, Parker, and Chen), Pathology (Drs Bahrami, Ellison, and Downing and Mr Dalton), Oncology (Drs Pappo and Federico), Biostatistics (Dr Wu and Ms Billups), Developmental Neurobiology (Dr Dyer), and the Hartwell Center for Bioinformatics and Biotechnology (Dr Wang and Mr Becksfort), St Jude Children's Research Hospital, Memphis, Tennessee

Department of Pathology , St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA

St Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project

2011

St Jude Children's Research Hospital

Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BE, London, UK

Prominent publications by David W Ellison

KOL-Index: 18954 . INTRODUCTION: We performed a genomic study in lung adenocarcinoma cases with discordant anaplastic lymphoma receptor tyrosine kinase gene (ALK) status by fluorescent in situ hybridization (FISH) and immunohistochemical (IHC) analysis. METHODS: DNA from formalin-fixed paraffin-embedded tissues of 16 discordant (four FISH-positive/IHC-negative and 12 FISH-negative/IHC-positive) cases by ...
Known for Lung Adenocarcinoma | Fish Ihc | Alk Gene | Situ Hybridization
KOL-Index: 16751 . Medulloblastoma is heterogeneous, being characterized by molecular subgroups that demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling pathway characterizes two of these molecular subgroups, the former associated with low-risk disease and the latter potentially targeted by novel SHH pathway inhibitors. This manuscript reports the validation of a novel ...
Known for Molecular Subgroups | Wnt Shh | Proteins Signal | Immunohistochemical Markers
KOL-Index: 15882 . Low-grade neuroepithelial tumors (LGNTs) are diverse CNS tumors presenting in children and young adults, often with a history of epilepsy. While the genetic profiles of common LGNTs, such as the pilocytic astrocytoma and ‘adult-type’ diffuse gliomas, are largely established, those of uncommon LGNTs remain to be defined. In this study, we have used massively parallel sequencing and various ...
Known for Genetic Alterations | Neuroepithelial Tumors | Braf Fgfr1 | Angiocentric Gliomas
KOL-Index: 15592 . CONTEXT: Neuroblastoma is diagnosed over a wide age range from birth through young adulthood, and older age at diagnosis is associated with a decline in survivability. OBJECTIVE: To identify genetic mutations that are associated with age at diagnosis in patients with metastatic neuroblastoma. DESIGN, SETTING, AND PATIENTS: Whole genome sequencing was performed on DNA from diagnostic tumors ...
Known for Genetic Mutations | Tumors Patients | Situ Hybridization | Age Diagnosis
KOL-Index: 15221 . BACKGROUND: Young children with medulloblastoma have a poor overall survival compared with older children, due to use of radiation-sparing therapy in young children. Radiotherapy is omitted or reduced in these young patients to spare them from debilitating long-term side-effects. We aimed to estimate event-free survival and define the molecular characteristics associated with ...
Known for Young Children | Chemotherapy Patients | Adapted Therapy | Adjuvant Child
KOL-Index: 13752 . Cancer stem cells are remarkably similar to normal stem cells: both self-renew, are multipotent and express common surface markers, for example, prominin 1 (PROM1, also called CD133). What remains unclear is whether cancer stem cells are the direct progeny of mutated stem cells or more mature cells that reacquire stem cell properties during tumour formation. Answering this question will ...
Known for Stem Cells | Neoplastic Transformation | Small Intestinal | Tumour Formation
KOL-Index: 13729 . BACKGROUND: Over half of childhood intracranial ependymomas occur in children younger than 5 years. As an adjuvant treatment, radiotherapy can be effective, but has the potential to damage the child's developing nervous system at a crucial time-with a resultant reduction in IQ and cognitive impairment, endocrinopathy, and risk of second malignancy. We aimed to assess the role of a primary ...
Known for Intracranial Ependymoma | Radiotherapy Children | 5 Years | Metastatic Disease
KOL-Index: 11740 . OBJECTIVE: Tumours of the choroid plexus are rare tumours of neuro-ectodermal origin, accounting for less than 1% of all intracranial tumours. Most cases present in children less than 2 years of age. While choroid plexus carcinomas (CPC) are reported to have an extremely poor prognosis, choroid plexus papillomas (CPP) are generally regarded as benign tumours with a very favourable ...
Known for Choroid Plexus | Cpc Cpp | Adjuvant Therapy | 6 Months
KOL-Index: 11460 . PURPOSE: CNS tumors are the most common second primary neoplasm (SPN) observed after childhood cancer in Britain, but the relationship of risk to doses of previous radiotherapy and chemotherapy is uncertain. METHODS: The British Childhood Cancer Survivor Study is a national, population-based, cohort study of 17,980 individuals surviving at least 5 years after diagnosis of childhood cancer. ...
Known for Cns Tumors | Childhood Cancer | Risk Meningioma | Radiationinduced Neoplasms
KOL-Index: 11362 . Medulloblastoma is the most common malignant brain tumor in childhood. Molecular studies from several groups around the world demonstrated that medulloblastoma is not one disease but comprises a collection of distinct molecular subgroups. However, all these studies reported on different numbers of subgroups. The current consensus is that there are only four core subgroups, which should be ...
Known for 4 Medulloblastomas | Molecular Subgroups | Clinical Data | Genetic Aberrations
KOL-Index: 11165 . BACKGROUND: Radiotherapy is an effective adjuvant treatment for brain tumours arising in very young children, but it has the potential to damage the child's developing nervous system at a crucial time - with a resultant reduction in IQ leading to cognitive impairment, associated endocrinopathy and risk of second malignancy. We aimed to assess the role of a primary chemotherapy strategy in ...
Known for 3 Years | Patients Medulloblastoma | Young Children | Early Childhood

Key People For Astrocytic Tumours

Top KOLs in the world
#1
David N Louis
allelic loss central nervous situ hybridization
#2
Paul Kleihues
p53 mutations secondary glioblastomas dna methylation
#3
Guido Reifenberger
mgmt promoter methylation central nervous malignant gliomas
#4
Bernd Walter Scheithauer
pituitary adenomas central nervous situ hybridization
#5
Vincent Peter Collins
human pair cell lines electron microscopy
#6
Otmar Dieter Wiestler
central nervous temporal lobe epilepsy cell lines

Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA | Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA | Department of Pathology, St. Jude Children’s Research Hospital, Memphi